CEO Anja Krammer表示:“隨著人口的老齡化,越來越多的老年人不得不面臨一種情況:衰老疾病只能進(jìn)行對癥治療,而新的投資者使Turn能將這種有望改善老年人生活質(zhì)量的技術(shù)推向市場。”參考資料:[1] Turn Biotechnologies completes latest round of funding(來源:美通社)[2] Sarkar, T. J. et al. Transientnon-integrative expression of nuclear reprogramming factors promotes multifaceted amelioration of aging in human cells. Nature Communications (2020)[3] Reprogram, rejuvenate, rewind: spinout(來源:Longevity Technology)